We are live on ! Find out more
MACM

March Altus Capital Management Portfolio holdings

AUM $16M
1-Year Est. Return 18.92%
This Fund
S&P 500
This Quarter Est. Return
+22.67%
1 Year Est. Return
+18.92%
3 Year Est. Return
+155.68%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$330M
AUM Growth
–
Cap. Flow
+$304M
Cap. Flow %
92.2%
Top 10 Hldgs %
51.11%
Holding
28
New
28
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
DXCM icon
DexCom
DXCM
+$26.4M
2
MON
Monsanto Co
MON
+$21.7M
3
ALKS icon
Alkermes
ALKS
+$17.1M
4
HCA icon
HCA Healthcare
HCA
+$17M
5
WST icon
West Pharmaceutical
WST
+$15.8M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 78.05%
2 Financials 8.92%
3 Materials 7.02%
4 Miscellaneous 3.31%
5 Industrials 2.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TMO icon
26
Thermo Fisher Scientific
TMO
$225B
$5.74M 1.74%
+51,545
New +$5.13M
ENZY
27
DELISTED
Enzymotec Ltd
ENZY
$5.48M 1.66%
+202,962
New +$4.83M
GNMK
28
DELISTED
GenMark Diagnostics, Inc
GNMK
$2.98M 0.9%
+223,818
New +$2.72M
1
2

Similar funds

IC
IKOS CIF Limassol, Cyprus $16.7M AUM 0.4% 1-Year Est. Return
PA
Para Advisors New York $17.5M AUM 3.99% 1-Year Est. Return
GMIM
General Motors Investment Management New York $20.3M AUM 55.51% 1-Year Est. Return
JHWCP
J.H. Whitney Capital Partners New Canaan, Connecticut $11.5M AUM 86.36% 1-Year Est. Return
SMPIAI
Spark Management Partners III (AIV I) Boston, Massachusetts $10.1M AUM 12.29% 1-Year Est. Return
NCMG
NCM Capital Management Group Durham, North Carolina $8.24M AUM 11.99% 1-Year Est. Return
CAD
Craig A. Drill $24.4M AUM 13.42% 1-Year Est. Return
GPI
Georgian Partners I Toronto, Ontario, Canada $25.3M AUM 21.88% 1-Year Est. Return

March Altus Capital Management's Q4 2013 Portfolio in Review

Q4 2013 is the first quarter with a 13F filing on record for March Altus Capital Management, which disclosed 28 positions worth $330M. Its ten largest holdings account for 51% of the portfolio.

Its largest position is DexCom: 3,339,352 shares worth $29.6M.

By sector, the portfolio is most concentrated in Healthcare at 78% of assets, followed by Financials and Materials.

  • March Altus Capital Management's largest Q4 2013 buy was DexCom: 3,339,352 shares worth $29.6M.
  • March Altus Capital Management's ten largest holdings make up 51% of its $330M portfolio in Q4 2013.
  • March Altus Capital Management disclosed 28 positions in Q4 2013, its first 13F filing on record.

Based on March Altus Capital Management's 13F filing for Q4 2013, filed 14 Feb 2014.